EQUASYM

Equasym Adverse Events Reported to the FDA Over Time

How are Equasym adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Equasym, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Equasym is flagged as the suspect drug causing the adverse event.

Most Common Equasym Adverse Events Reported to the FDA

What are the most common Equasym adverse events reported to the FDA?

Tic	52 (6.97%)
Benign Intracranial Hypertension	20 (2.68%)
Fatigue	20 (2.68%)
Suicide Attempt	20 (2.68%)
Eye Swelling	19 (2.55%)
Condition Aggravated	13 (1.74%)
Headache	13 (1.74%)
Sleep Disorder	11 (1.47%)
Aggression	10 (1.34%)
Eye Pain	10 (1.34%)
Eye Pruritus	10 (1.34%)
	Show More
Visual Impairment	10 (1.34%)
Crying	9 (1.21%)
Eyelid Oedema	9 (1.21%)
Incorrect Dose Administered	9 (1.21%)
Ocular Hyperaemia	9 (1.21%)
Papilloedema	9 (1.21%)
Tachycardia	9 (1.21%)
Alanine Aminotransferase Increased	8 (1.07%)
Anxiety	8 (1.07%)
Conjunctivitis	8 (1.07%)
Csf Pressure Increased	8 (1.07%)
Overdose	8 (1.07%)
Restlessness	8 (1.07%)
Vomiting	8 (1.07%)
Depression	7 (.94%)
Drug Ineffective	7 (.94%)
Intentional Overdose	7 (.94%)
Accidental Drug Intake By Child	6 (.8%)
Bipolar Disorder	6 (.8%)
Hypotonia	6 (.8%)
Weight Decreased	6 (.8%)
Abnormal Behaviour	5 (.67%)
Accidental Exposure	5 (.67%)
Contusion	5 (.67%)
Drug Abuse	5 (.67%)
Euphoric Mood	5 (.67%)
Gastrointestinal Pain	5 (.67%)
Haematuria	5 (.67%)
Hypersensitivity	5 (.67%)
Malaise	5 (.67%)
White Blood Cell Count Decreased	5 (.67%)
Abdominal Pain	4 (.54%)
Affective Disorder	4 (.54%)
Agitation	4 (.54%)
Blood Pressure Increased	4 (.54%)
Decreased Appetite	4 (.54%)
Dizziness	4 (.54%)
Encopresis	4 (.54%)
Enuresis	4 (.54%)
Eye Irritation	4 (.54%)
Movement Disorder	4 (.54%)
Muscle Twitching	4 (.54%)
Off Label Use	4 (.54%)
Rash	4 (.54%)
Strabismus	4 (.54%)
Tremor	4 (.54%)
Urinary Retention	4 (.54%)
Abscess Neck	3 (.4%)
Anaemia	3 (.4%)
Aspartate Aminotransferase Increase...	3 (.4%)
Blood Creatine Phosphokinase Increa...	3 (.4%)
Drug Exposure During Pregnancy	3 (.4%)
Dysarthria	3 (.4%)
Dyspepsia	3 (.4%)
Lymphadenopathy	3 (.4%)
Meningitis	3 (.4%)
Morose	3 (.4%)
Multiple Drug Overdose Intentional	3 (.4%)
Mydriasis	3 (.4%)
Oedema Peripheral	3 (.4%)
Oropharyngeal Pain	3 (.4%)
Paraesthesia	3 (.4%)
Psychomotor Hyperactivity	3 (.4%)
Purpura	3 (.4%)
Pyrexia	3 (.4%)
Rash Generalised	3 (.4%)
Social Avoidant Behaviour	3 (.4%)
Thrombosis	3 (.4%)
Visual Acuity Reduced	3 (.4%)
Weight Increased	3 (.4%)
Abdominal Pain Upper	2 (.27%)
Accidental Overdose	2 (.27%)
Acute Febrile Neutrophilic Dermatos...	2 (.27%)
Alcohol Abuse	2 (.27%)
Anger	2 (.27%)
Anorexia	2 (.27%)
Apathy	2 (.27%)
Arrhythmia	2 (.27%)
Arthralgia	2 (.27%)
Blister	2 (.27%)
Cardiac Disorder	2 (.27%)
Chest Pain	2 (.27%)
Confusional State	2 (.27%)
Conjunctivitis Allergic	2 (.27%)
Convulsion	2 (.27%)
Dependence	2 (.27%)
Depressed Mood	2 (.27%)
Diarrhoea	2 (.27%)
Diplopia	2 (.27%)
Disease Recurrence	2 (.27%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Equasym, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Equasym is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Equasym

What are the most common Equasym adverse events reported to the FDA?

Changes In Physical Activity	60 (8.04%)
Medication Errors	44 (5.9%)
Ocular Infections, Irritations And ...	44 (5.9%)
Eye	31 (4.16%)
Neurological	27 (3.62%)
Gastrointestinal Signs	25 (3.35%)
Suicidal And Self-injurious Behavio...	24 (3.22%)
Increased Intracranial Pressure And...	20 (2.68%)
Mood Disorders	19 (2.55%)
Hepatobiliary	16 (2.14%)
Urinary Tract Signs	16 (2.14%)
	Show More
Personality Disorders	15 (2.01%)
Psychiatric	15 (2.01%)
Vision	15 (2.01%)
Epidermal And Dermal Conditions	14 (1.88%)
Sleep Disorders	14 (1.88%)
Anxiety Disorders	13 (1.74%)
Cardiac Arrhythmias	13 (1.74%)
Depressed Mood Disorders	13 (1.74%)
Headaches	13 (1.74%)
Hematology Investigations	13 (1.74%)
Infections - Pathogen Unspecified	13 (1.74%)
Movement Disorders	12 (1.61%)
Therapeutic And Nontherapeutic Effe...	11 (1.47%)
Cardiac And Vascular Investigations	10 (1.34%)
Ocular Structural Change, Deposit A...	10 (1.34%)
Neurological, Special Senses And Ps...	9 (1.21%)
Ocular Neuromuscular	9 (1.21%)
Physical Examination Topics	9 (1.21%)
Appetite And General Nutritional	7 (.94%)
Neuromuscular	7 (.94%)
Psychiatric And Behavioural Symptom...	7 (.94%)
Manic And Bipolar Mood Disorders	6 (.8%)
Muscle	6 (.8%)
Respiratory	6 (.8%)
Allergic Conditions	5 (.67%)
Bacterial Infectious	5 (.67%)
Injuries	5 (.67%)
Joint	5 (.67%)
Seizures	5 (.67%)
Therapeutic Procedures And Supporti...	5 (.67%)
Body Temperature Conditions	4 (.54%)
Disturbances In Thinking	4 (.54%)
Anemias Nonhemolytic And Marrow Dep...	3 (.4%)
Cardiac Disorder Signs	3 (.4%)
Chemical Injury And Poisoning	3 (.4%)
Deliria	3 (.4%)
Embolism And Thrombosis	3 (.4%)
Enzyme	3 (.4%)
Impulse Control	3 (.4%)
Skin Vascular Abnormalities	3 (.4%)
Spleen, Lymphatic And Reticulendoth...	3 (.4%)
Vascular	3 (.4%)
White Blood Cell	3 (.4%)
Bronchial Disorders	2 (.27%)
Central Nervous System Vascular	2 (.27%)
Eating Disorders	2 (.27%)
Family Issues	2 (.27%)
Gastrointestinal Motility And Defec...	2 (.27%)
Inner Ear And Viiith Cranial Nerve	2 (.27%)
Musculoskeletal And Connective Tiss...	2 (.27%)
Ocular Sensory Symptoms	2 (.27%)
Product Quality Issues	2 (.27%)
Schizophrenia And Other Psychotic	2 (.27%)
Sleep Disturbances	2 (.27%)
Angiedema And Urticaria	1 (.13%)
Breast	1 (.13%)
Communication Disorders	1 (.13%)
Cytoplasmic Disorders Congenital	1 (.13%)
Decreased And Nonspecific Blood Pre...	1 (.13%)
Electrolyte And Fluid Balance Condi...	1 (.13%)
Glaucoma And Ocular Hypertension	1 (.13%)
Legal Issues	1 (.13%)
Lifestyle Issues	1 (.13%)
Mental Impairment	1 (.13%)
Myocardial	1 (.13%)
Nephropathies	1 (.13%)
Neurological Disorders Of The Eye	1 (.13%)
Ocular Hemorrhages And Vascular	1 (.13%)
Pregnancy, Labour, Delivery And Pos...	1 (.13%)
Reproductive Tract	1 (.13%)
Retina, Choroid And Vitreous Hemorr...	1 (.13%)
Salivary Gland Conditions	1 (.13%)
Tendon, Ligament And Cartilage	1 (.13%)
Viral Infectious	1 (.13%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Equasym, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Equasym is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.